beta amyloid fibril formation inhibitors (Korea Institute of Science and Technology/Seoul National University/Hanmi Pharmaceutical)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namebeta amyloid fibril formation inhibitors (Korea Institute of Science and Technology/Seoul National University/Hanmi Pharmaceutical)
Drug Alias NameKMS-88 seriesbeta amyloid fibril formation inhibitors (Korea Institute of Science and Technology/Seoul National University)KMS-88016KMS-88009KMSB-600
ClassificationSmall molecules
Mechanisms of ActionBeta amyloid A4 protein inhibitorsNeuroprotectants
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A